Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Molecular Predictors of Lung Cancer Behavior. (SPORE)
Multiple Cancer Types
Lung,
Non Small Cell,
Small Cell
N/A
Massion, Pierre
NCT00898313
VICCTHO0398
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Multiple Cancer Types
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with LS-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Lung,
Small Cell
III
Iams, Wade
NCT03703297
VICCTHO1901
Ifetroban in Treating Patients with Malignant Solid Tumors at High Risk of Metastatic Recurrence
Multiple Cancer Types
This phase II trial studies the side effects of ifetroban in treating patients with malignant solid tumors that are at high risk of coming back after treatment (recurrent) and spreading throughout the body (metastatic). Platelets are a type of blood cells that help with clotting. Cancer cells stick to platelets and ride on them to get to different parts of the body. Drugs, such as ifetroban, may help these platelets become less "sticky," and reduce the chance of cancer cells spreading to other places in the body.
Breast,
Esophageal,
Gastric/Gastroesophageal,
Lung,
Non Small Cell,
Pancreatic,
Small Cell
II
Mayer, Ingrid
NCT03694249
VICCMD1854
